Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.

Ludovico MessineoLuigi Taranto-MontemurroNicole CalianeseLaura K GellAli AzarbarzinGonzalo LabarcaDan VenaHyung Chae YangTsai-Yu WangAndrew WellmanScott A Sands

Published in: Respirology (Carlton, Vic.) (2022)

While inefficacious in unselected patients, Ato-Feso administered for one night suppressed OSA in patients with milder collapsibility. Ato-Feso may hold some promise as an alternative OSA treatment in certain subgroups of individuals.

Keyphrases

obstructive sleep apnea
positive airway pressure
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
attention deficit hyperactivity disorder
big data